Critical issues and pitfalls in serum and plasma handling for complement analysis in nanomedicine and bionanotechnology

被引:17
作者
Moghimi, S. Moein [1 ,2 ,3 ]
Simberg, Dmitri [3 ,4 ]
机构
[1] Newcastle Univ, Sch Pharm, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Newcastle Univ, Translat & Clin Res Inst, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[3] Univ Colorado, Colorado Ctr Nanomed & Nanosafety, Anschutz Med Campus, Aurora, CO 80045 USA
[4] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Translat Bionanosci Lab, Anschutz Med Campus, Aurora, CO 80045 USA
关键词
Bovine; Complement; Human; Mouse; Nanomedicine; Plasma; Serum; ALTERNATIVE PATHWAY; PROTEIN CORONA; ACTIVATES COMPLEMENT; BIOLOGICAL IDENTITY; IN-VIVO; TARGET;
D O I
10.1016/j.nantod.2022.101479
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The complement system is a group of soluble and membrane-bound proteins belonging to the innate arm of the immune system, offering protection against intruders, including drug delivery systems, as well as regulating host homeostasis. However, when uncontrolled, complement activation could trigger in-flammatory reactions. Considering these, careful assessment of complement activation by particulate medicines becomes important, since over activation of the complement system could negatively impact their therapeutic potential. For careful complement analysis, meticulous handling and characterisation of sera/plasma is needed but regularly omitted by the research community. Here, we draw attention to this problem and call for implementation of quality assessment guidelines in sera/plasma preparation, storage and validation. We further highlight critical and variable biological factors that affect complement eva-luation. These measure are necessary for reproducible complement mapping and for eliminating erroneous conclusions on complement evasion/activation properties of investigational and regulatory-approved par-ticulate medicines.(c) 2022 Elsevier Ltd. All rights reserved.
引用
收藏
页数:7
相关论文
共 58 条
[1]   The protein corona of dendrimers: PAMAM binds and activates complement proteins in human plasma in a generation dependent manner [J].
Akesson, Anna ;
Cardenas, Marite ;
Elia, Giuliano ;
Monopoli, Marco P. ;
Dawson, Kenneth A. .
RSC ADVANCES, 2012, 2 (30) :11245-11248
[2]   Molecular Intercommunication between the Complement and Coagulation Systems [J].
Amara, Umme ;
Flierl, Michael A. ;
Rittirsch, Daniel ;
Klos, Andreas ;
Chen, Hui ;
Acker, Barbara ;
Brueckner, Uwe B. ;
Nilsson, Bo ;
Gebhard, Florian ;
Lambris, John D. ;
Huber-Lang, Markus .
JOURNAL OF IMMUNOLOGY, 2010, 185 (09) :5628-5636
[3]   SEXUAL DIMORPHISM OF THE 5TH COMPONENT OF MOUSE COMPLEMENT [J].
BABA, A ;
FUJITA, T ;
TAMURA, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :411-419
[4]   Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population [J].
Benasutti, Halli ;
Wang, Guankui ;
Vu, Vivian P. ;
Scheinman, Robert ;
Groman, Ernest ;
Saba, Laura ;
Simberg, Dmitri .
BIOCONJUGATE CHEMISTRY, 2017, 28 (11) :2747-2755
[5]   Commercially Available Complement Component-Depleted Sera Are Unexpectedly Codepleted of Ficolin-2 [J].
Brady, Allison M. ;
Geno, K. Aaron ;
Dalecki, Alex G. ;
Cheng, Xiaogang ;
Nahm, Moon H. .
CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (09) :1323-1329
[6]   Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona [J].
Caracciolo, Giulio ;
Farokhzad, Omid C. ;
Mahmoudi, Morteza .
TRENDS IN BIOTECHNOLOGY, 2017, 35 (03) :257-264
[7]   Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations [J].
Cedrone, Edward ;
Neun, Barry W. ;
Rodriguez, Jamie ;
Vermilya, Alison ;
Clogston, Jeffrey D. ;
McNeil, Scott E. ;
Barenholz, Yechezkel ;
Szebeni, Janos ;
Dobrovolskaia, Marina A. .
MOLECULES, 2018, 23 (01)
[8]   Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population [J].
da Costa, Mariana Gaya ;
Poppelaars, Felix ;
van Kooten, Cees ;
Mollnes, Tom E. ;
Tedesco, Francesco ;
Wuerzner, Reinhard ;
Trouw, Leendert A. ;
Truedsson, Lennart ;
Daha, Mohamed R. ;
Roos, Anja ;
Seelen, Marc A. .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[9]  
DISCIPIO RG, 1982, IMMUNOLOGY, V45, P587
[10]   Minimum information reporting in bio-nano experimental literature [J].
Faria, Matthew ;
Bjornmalm, Mattias ;
Thurecht, Kristofer J. ;
Kent, Stephen J. ;
Parton, Robert G. ;
Kavallaris, Maria ;
Johnston, Angus P. R. ;
Gooding, J. Justin ;
Corrie, Simon R. ;
Boyd, Ben J. ;
Thordarson, Pall ;
Whittaker, Andrew K. ;
Stevens, Molly M. ;
Prestidge, Clive A. ;
Porter, Christopher J. H. ;
Parak, Wolfgang J. ;
Davis, Thomas P. ;
Crampin, Edmund J. ;
Caruso, Frank .
NATURE NANOTECHNOLOGY, 2018, 13 (09) :777-785